首页 | 本学科首页   官方微博 | 高级检索  
检索        


NO•/RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer
Authors:Limin Wang  Wei Tang  Shouhui Yang  Peijun He  Jian Wang  Jochen Gaedcke  Philipp Ströbel  Azadeh Azizian  Thomas Ried  Matthias M Gaida  Harris G Yfantis  Dong H Lee  Ashish Lal  Benoit J Van den Eynde  H Richard Alexander  B Michael Ghadimi  Nader Hanna  S Perwez Hussain
Institution:1. Pancreatic Cancer Section, Laboratory of Human Carcinogenesis, CCR, NCI, Bethesda, MD;2. Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, CCR, NCI, Bethesda, MD;3. Department of General, Visceral and Pediatric Surgery, University Medicine, Göttingen, Germany;4. Cancer Genomics Section, Genetics Branch, CCR, NCI, Bethesda, MD;5. Institute of Pathology University Hospital, Heidelberg, Germany;6. Pathology and Laboratory Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, MD;7. Regulatory RNAs and Cancer Section, Genetics Branch, CR, NCI, Bethesda, MD;8. Ludwig Institute for Cancer Research, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium;9. Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ;10. Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, MD
Abstract:
Keywords:pancreatic cancer  kynurenine  nitric oxide  RUNX3  therapeutic targets  prognosis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号